Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PEGINTERFERON BETA-1A for Demyelination: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 7 adverse event reports in the FDA FAERS database where PEGINTERFERON BETA-1A was used for Demyelination.

Most Reported Side Effects for PEGINTERFERON BETA-1A

Side Effect Reports % Deaths Hosp.
Influenza like illness 1,431 11.5% 2 174
Injection site erythema 1,041 8.4% 0 119
Multiple sclerosis relapse 945 7.6% 2 578
Fatigue 673 5.4% 2 142
Headache 587 4.7% 0 105
Pain 580 4.7% 2 111
Injection site reaction 569 4.6% 1 51
Device malfunction 567 4.6% 0 9
Multiple sclerosis 536 4.3% 14 153
Pyrexia 503 4.0% 4 135
Memory impairment 455 3.7% 1 45
Malaise 448 3.6% 3 101
Injection site pain 435 3.5% 0 35
Fall 406 3.3% 5 214
Drug dose omission 389 3.1% 0 12

Other Indications for PEGINTERFERON BETA-1A

Multiple sclerosis (11,105) Product used for unknown indication (817) Relapsing-remitting multiple sclerosis (390) Maternal exposure timing unspecified (82) Secondary progressive multiple sclerosis (11) Relapsing multiple sclerosis (6)

Other Drugs Used for Demyelination

RITUXIMAB (185) METHYLPREDNISOLONE (52) HUMAN IMMUNOGLOBULIN G (41) TOCILIZUMAB (20) TERIFLUNOMIDE (19) OCRELIZUMAB (18) PREDNISONE (16) PREDNISOLONE (15) SATRALIZUMAB-MWGE (15) DEXAMETHASONE (13)

Related Pages

PEGINTERFERON BETA-1A Full Profile All Demyelination Drugs PEGINTERFERON BETA-1A Demographics PEGINTERFERON BETA-1A Timeline